TRIB logo

Trinity Biotech (TRIB) Long Term Liabilities

Annual Total Long Term Liabilities

$68.35 M
-$8.59 M-11.17%

31 December 2023

TRIB Long Term Liabilities Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Quarterly Long Term Liabilities

$95.73 M
-$2.25 M-2.30%

30 September 2024

TRIB Quarterly Long Term Liabilities Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

TRIB Long Term Liabilities Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-11.2%+40.1%
3 y3 years-35.3%+401.4%
5 y5 years-24.1%-11.7%

TRIB Long Term Liabilities High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3 years-35.3%+265.1%-2.3%+411.3%
5 y5 years-36.1%+265.1%-11.7%+411.3%
alltimeall time-47.3%>+9999.0%-28.8%>+9999.0%

Trinity Biotech Long Term Liabilities History

DateAnnualQuarterly
Sept 2024
-
$95.73 M(-2.3%)
June 2024
-
$97.98 M(+8.5%)
Mar 2024
-
$90.34 M(+32.2%)
Dec 2023
$68.35 M(-11.2%)
$68.35 M(+0.0%)
Sept 2023
-
$68.35 M(-0.4%)
June 2023
-
$68.61 M(-15.9%)
Mar 2023
-
$81.63 M(+6.1%)
Dec 2022
$76.94 M(+310.9%)
$76.94 M(+0.5%)
Sept 2022
-
$76.53 M(-1.2%)
June 2022
-
$77.44 M(-19.7%)
Mar 2022
-
$96.44 M(+415.1%)
Dec 2021
$18.72 M(-82.3%)
$18.72 M(-1.9%)
Sept 2021
-
$19.09 M(-2.6%)
June 2021
-
$19.60 M(-81.2%)
Mar 2021
-
$104.46 M(-1.0%)
Dec 2020
$105.56 M(-1.3%)
$105.56 M(-0.3%)
Sept 2020
-
$105.91 M(-0.7%)
June 2020
-
$106.69 M(+0.4%)
Mar 2020
-
$106.30 M(-0.6%)
Dec 2019
$106.91 M(+18.8%)
$106.91 M(-1.4%)
Sept 2019
-
$108.42 M(+0.2%)
June 2019
-
$108.22 M(-0.4%)
Mar 2019
-
$108.66 M(+20.7%)
Dec 2018
$90.00 M(-15.5%)
$90.00 M(-4.6%)
Sept 2018
-
$94.38 M(-11.8%)
June 2018
-
$106.96 M(+0.2%)
Mar 2018
-
$106.75 M(+0.2%)
Dec 2017
$106.55 M(-7.8%)
$106.55 M(-7.1%)
Sept 2017
-
$114.74 M(+0.0%)
June 2017
-
$114.70 M(-0.0%)
Mar 2017
-
$114.71 M(-0.8%)
Dec 2016
$115.58 M(-10.8%)
$115.58 M(-10.6%)
Sept 2016
-
$129.25 M(+1.8%)
June 2016
-
$126.99 M(-0.2%)
Mar 2016
-
$127.27 M(-1.8%)
Dec 2015
$129.65 M(+444.5%)
$129.65 M(+4.0%)
Sept 2015
-
$124.66 M(-7.2%)
June 2015
-
$134.38 M(+440.1%)
Mar 2015
-
$24.88 M(+4.5%)
Dec 2014
$23.81 M(+5.8%)
$23.81 M(-9.9%)
Sept 2014
-
$26.44 M(+5.2%)
June 2014
-
$25.12 M(+8.5%)
Mar 2014
-
$23.15 M(+2.9%)
Dec 2013
$22.50 M(+49.4%)
$22.50 M(-9.2%)
Sept 2013
-
$24.77 M(+76.9%)
June 2013
-
$14.00 M(-3.5%)
Mar 2013
-
$14.51 M(-3.7%)
Dec 2012
$15.06 M(+120.3%)
$15.06 M(+37.6%)
Sept 2012
-
$10.94 M(+2.0%)
June 2012
-
$10.72 M(+1.5%)
Mar 2012
-
$10.56 M(+54.5%)
Dec 2011
$6.84 M(-6.7%)
$6.84 M(-15.7%)
Sept 2011
-
$8.12 M(+4.1%)
June 2011
-
$7.79 M(+6.9%)
Mar 2011
-
$7.29 M(-0.6%)
DateAnnualQuarterly
Dec 2010
$7.33 M(-73.3%)
$7.33 M(-4.0%)
Sept 2010
-
$7.64 M(+2.2%)
June 2010
-
$7.48 M(-69.6%)
Mar 2010
-
$24.61 M(-10.5%)
Dec 2009
$27.50 M(-1.4%)
$27.50 M(+19.7%)
Sept 2009
-
$22.98 M(-10.9%)
June 2009
-
$25.79 M(+4.5%)
Mar 2009
-
$24.69 M(-11.5%)
Dec 2008
$27.90 M(-21.7%)
$27.90 M(-16.2%)
Sept 2008
-
$33.29 M(-9.4%)
June 2008
-
$36.74 M(+16.4%)
Mar 2008
-
$31.58 M(-11.4%)
Dec 2007
$35.62 M(-22.4%)
$35.62 M(-8.8%)
June 2007
-
$39.05 M(-4.7%)
Mar 2007
-
$40.99 M(-10.7%)
Dec 2006
$45.93 M(+140.7%)
$45.93 M(+4.0%)
Sept 2006
-
$44.17 M(-8.2%)
June 2006
-
$48.13 M(+201.5%)
Mar 2006
-
$15.96 M(-16.3%)
Dec 2005
$19.08 M(+32.2%)
$19.08 M(+4.4%)
Sept 2005
-
$18.27 M(+45.8%)
June 2005
-
$12.54 M(-11.4%)
Mar 2005
-
$14.15 M(-1.9%)
Dec 2004
$14.43 M(-21.7%)
$14.43 M(-34.1%)
Sept 2004
-
$21.91 M(-7.9%)
June 2004
-
$23.79 M(+6.1%)
Mar 2004
-
$22.42 M(+21.7%)
Dec 2003
$18.43 M(+129.2%)
$18.43 M(-26.0%)
Sept 2003
-
$24.89 M(+407.0%)
June 2003
-
$4.91 M(-30.2%)
Mar 2003
-
$7.04 M(-12.5%)
Dec 2002
$8.04 M(+3.0%)
$8.04 M(+19.2%)
Sept 2002
-
$6.74 M(-0.3%)
June 2002
-
$6.76 M(-10.6%)
Mar 2002
-
$7.57 M(-3.0%)
Dec 2001
$7.80 M(+244.4%)
$7.80 M(+59.9%)
Sept 2001
-
$4.88 M(+2.2%)
June 2001
-
$4.78 M(+120.1%)
Mar 2001
-
$2.17 M(-4.3%)
Dec 2000
$2.27 M(-72.0%)
$2.27 M(-60.2%)
Sept 2000
-
$5.70 M(-11.1%)
June 2000
-
$6.41 M(-26.0%)
Mar 2000
-
$8.66 M(+7.1%)
Dec 1999
$8.09 M(-34.3%)
$8.09 M(-10.2%)
Sept 1999
-
$9.00 M(-12.6%)
June 1999
-
$10.30 M(-12.7%)
Mar 1999
-
$11.80 M(-4.2%)
Dec 1998
$12.31 M(+41.5%)
$12.31 M(-32.7%)
Sept 1998
-
$18.30 M(+94.7%)
June 1998
-
$9.40 M(+8.0%)
Dec 1997
$8.70 M(-3000.0%)
$8.70 M(-3000.0%)
Dec 1996
-$300.00 K(-400.0%)
-$300.00 K(-400.0%)
Dec 1994
$100.00 K(0.0%)
-
Feb 1994
-
$100.00 K
Feb 1994
$100.00 K
-

FAQ

  • What is Trinity Biotech annual total long term liabilities?
  • What is the all time high annual total long term liabilities for Trinity Biotech?
  • What is Trinity Biotech annual total long term liabilities year-on-year change?
  • What is Trinity Biotech quarterly total long term liabilities?
  • What is the all time high quarterly long term liabilities for Trinity Biotech?
  • What is Trinity Biotech quarterly long term liabilities year-on-year change?

What is Trinity Biotech annual total long term liabilities?

The current annual total long term liabilities of TRIB is $68.35 M

What is the all time high annual total long term liabilities for Trinity Biotech?

Trinity Biotech all-time high annual total long term liabilities is $129.65 M

What is Trinity Biotech annual total long term liabilities year-on-year change?

Over the past year, TRIB annual total long term liabilities has changed by -$8.59 M (-11.17%)

What is Trinity Biotech quarterly total long term liabilities?

The current quarterly long term liabilities of TRIB is $95.73 M

What is the all time high quarterly long term liabilities for Trinity Biotech?

Trinity Biotech all-time high quarterly total long term liabilities is $134.38 M

What is Trinity Biotech quarterly long term liabilities year-on-year change?

Over the past year, TRIB quarterly total long term liabilities has changed by +$27.39 M (+40.07%)